CLINICAL_TRIALS
trial_result
· 2021-03-22
Clinical Trial Update: Ketamine and Prolonged Exposure in PTSD [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating ketamine in combination with prolonged exposure therapy for post-traumatic stress disorder has completed with results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Post-traumatic Stress Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-22